Effects of maternal stress and perinatal fluoxetine exposure on behavioral outcomes of adult male offspring

Neuroscience

Volumn 320, Issue , 2016, Pages 281-296

  Kiryanova, V ^a,c   Meunier, S J ^a,c   Vecchiarelli, H A ^c   Hill, M N ^b,c   Dyck, R H ^a,b,c  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

Aggression; Anxiety; BDNF; Behavior; Prenatal stress; SSRI

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; FLUOXETINE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR;

ADULT; AGGRESSION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; BEHAVIOR; COGNITION; CONTROLLED STUDY; FEMALE; FRONTAL CORTEX; HYPERACTIVITY; MALE; MATERNAL BEHAVIOR; MATERNAL STRESS; MENTAL PERFORMANCE; NONHUMAN; PERINATAL DRUG EXPOSURE; PRENATAL STRESS; PRIORITY JOURNAL; PROGENY; RISK ASSESSMENT; SENSORIMOTOR FUNCTION; SEROTONIN BRAIN LEVEL; ANIMAL; ANIMAL BEHAVIOR; BRAIN; C57BL MOUSE; DISEASE MODEL; DRUG EFFECTS; MENTAL STRESS; MOUSE; PREGNANCY; PRENATAL EXPOSURE;

AGGRESSION; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; DISEASE MODELS, ANIMAL; FEMALE; FLUOXETINE; MALE; MATERNAL BEHAVIOR; MICE; MICE, INBRED C57BL; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SEROTONIN UPTAKE INHIBITORS; STRESS, PSYCHOLOGICAL;

EID: 84958268093     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2016.01.064     Document Type: Article

References (119)

1. Alwan S., Friedman J.M. Safety of selective serotonin reuptake inhibitors in pregnancy. CNS Drugs 2009, 23:493-509.
2. Andersson L., Sundström-Poromaa I., Bixo M., Wulff M., Bondestam K., Åström M. Point prevalence of psychiatric disorders during the second trimester of pregnancy: a population-based study. Am J Obstet Gynecol 2003, 189:148-154.
3. Andrade S.E., Raebel M.A., Brown J., Lane K., Livingston J., Boudreau D., Rolnick S.J., Roblin D., Smith D.H., Willy M.E., Staffa J.A. Platt R Use of antidepressant medications during pregnancy: a multisite study. Am J Obstet Gynecol 2008, 198. 194.e191-195.
4. Ansorge M.S., Morelli E., Gingrich J.A. Inhibition of serotonin but not norepinephrine transport during development produces delayed, persistent perturbations of emotional behaviors in mice. J Neurosci 2008, 28:199-207.
5. Ansorge M.S., Zhou M., Lira A., Hen R., Gingrich J.A. Early-life blockade of the 5-HT transporter altersemotional behavior in adult mice. Science 2004, 306:879-881.
6. Behan A.T., van den Hove D.L., Mueller L., Jetten M.J., Steinbusch H.W., Cotter D.R., Prickaerts J. Evidence of female-specific glial deficits in the hippocampus in a mouse model of prenatal stress. Eur Neuropsychopharmacol 2011, 21:71-79.
7. Bengel D., Murphy D.L., Andrews A.M., Wichems C.H., Feltner D., Heils A., Mössner R., Westphal H., Lesch K.P. Altered brain serotonin homeostasis and locomotor insensitivity to 3,4-methylenedioxymethamphetamine ("Ecstasy") in serotonin transporter-deficient mice. Mol Pharmacol 1998, 53:649-655.
8. Berman M.E., McCloskey M.S., Fanning J.R., Schumacher J.A., Coccaro E.F. Serotonin augmentation reduces response to attack in aggressive individuals. Psychol Sci 2009, 20:714-720.
9. Beydoun H., Saftlas A.F. Physical and mental health outcomes of prenatal maternal stress in human and animal studies: a review of recent evidence. Paediatr Perinat Epidemiol 2008, 22:438-466.
10. Biala Ya N., Bogoch Y., Bejar C., Linial M., Weinstock M. Prenatal stress diminishes gender differences in behavior and in expression of hippocampal synaptic genes and proteins in rats. Hippocampus 2011, 21:1114-1125.
11. Bosch O.J., Kromer S.A., Neumann I.D. Prenatal stress: opposite effects on anxiety and hypothalamic expression of vasopressin and corticotropin-releasing hormone in rats selectively bred for high and low anxiety. Eur J Neurosci 2006, 23:541-551.
12. Bosch O.J., Musch W., Bredewold R., Slattery D.A., Neumann I.D. Prenatal stress increases HPA axis activity and impairs maternal care in lactating female offspring: implications for postpartum mood disorder. Psychoneuroendocrinology 2007, 32:267-278.
13. Brent N.B., Wisner K.L. Fluoxetine and carbamazepine concentrations in a nursing mother/infant pair. Clin Pediatr (Phila) 1998, 37:41-44.
14. Bustamante C., Bilbao P., Contreras W., Martinez M., Mendoza A., Reyes A., Pascual R. Effects of prenatal stress and exercise on dentate granule cells maturation and spatial memory in adolescent mice. Int J Dev Neurosci 2010, 28:605-609.
15. Cabrera-Vera T.M., Garcia F., Pinto W., Battaglia G. Effect of prenatal fluoxetine (Prozac) exposure on brain serotonin neurons in prepubescent and adult male rat offspring. J Pharmacol Exp Ther 1997, 280:138-145.
16. Capello C.F., Bourke C.H., Ritchie J.C., Stowe Z.N., Newport D.J., Nemeroff A., Owens M.J. Serotonin transporter occupancy in rats exposed to serotonin reuptake inhibitors in utero or via breast milk. J Pharmacol Exp Ther 2011, 339:275-285.
17. Carrillo M., Ricci L.A., Coppersmith G.A., Melloni R.H. The effect of increased serotonergic neurotransmission on aggression: a critical meta-analytical review of preclinical studies. Psychopharmacology (Berl) 2009, 205:349-368.
18. Chourbaji S., Hoyer C., Richter S.H., Brandwein C., Pfeiffer N., Vogt M.A., Vollmayr B., Gass P. Differences in mouse maternal care behavior - is there a genetic impact of the glucocorticoid receptor?. PLoS One 2011, 6.
19. Clancy B., Kersh B., Hyde J., Darlington R.B., Anand K.J., FB L. Web-based method for translating neurodevelopment from laboratory species to humans. Neuroinformatics 2007, 5:79-94.
20. Cleare A.J., Bond A.J. The effect of tryptophan depletion and enhancement on subjective and behavioural aggression in normal male subjects. Psychopharmacology (Berl) 1995, 118:72-81.
21. Cleare A.J., Bond A.J. Does central serotonergic function correlate inversely with aggression? A study using D-fenfluramine in healthy subjects. Psychiatry Res 1997, 69:89-95.
22. Cooper W.O., Willy M.E., Pont S.J., Ray W.A. Increasing use of antidepressants in pregnancy. Am J Obstet Gynecol 2007, 196. 544.e541-545.
23. Cruz A.P., Frei F., Graeff F.G. Ethopharmacological analysis of rat behavior on the elevated plus-maze. Pharmacol Biochem Behav 1994, 49:171-176.
24. da-Silva V.A., Altenburg S.P., Malheiros L.R., Thomaz T.G., Lindsey C.J. Postnatal development of rats exposed to fluoxetine or venlafaxine during the third week of pregnancy. Braz J Med Biol Res 1999, 32:93-98.
25. de Boer S.F., Lesourd M., Mocaer E., Koolhaas J.M. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: a comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635. J Pharmacol Exp Ther 1999, 288:1125-1133.
26. Dolan M., Anderson I.M., Deakin J.F. Relationship between 5-HT function and impulsivity and aggression in male offenders with personality disorders. Br J Psychiatry 2001, 178:352-359.
27. Dugovic C., Maccari S., Weibel L., Turek F.W., Van Reeth O. High corticosterone levels in prenatally stressed rats predict persistent paradoxical sleep alterations. J Neurosci 1999, 19:8656-8664.
28. Duke A.A., Begue L., Bell R., Eisenlohr-Moul T. Revisiting the serotonin-aggression relation in humans: a meta-analysis. Psychol Bull 2013, 139:1148-1172.
29. Epperson C.N., Jatlow P.I., Czarkowski K., Anderson G.M. Maternal fluoxetine treatment in the postpartum period: effects on platelet serotonin and plasma drug levels in breastfeeding mother-infant pairs. Pediatrics 2003, 112:e425.
30. Fumagalli F., Bedogni F., Perez J., Racagni G., Riva M.A. Corticostriatal brain-derived neurotrophic factor dysregulation in adult rats following prenatal stress. Eur J Neurosci 2004, 20:1348-1354.
31. Gavin N.I., Gaynes B.N., Lohr K.N., Meltzer-Brody S., Gartlehner G., Swinson T. Perinatal depression: a systematic review of prevalence and incidence. Obstet Gynecol 2005, 106:1071-1083.
32. Grippo A.J., Beltz T.G., Johnson A.K. Behavioral and cardiovascular changes in the chronic mild stress model of depression. Physiol Behav 2003, 78:703-710.
33. Gronli J., Murison R., Fiske E., Bjorvatn B., Sorensen E., Portas C.M., Ursin R. Effects of chronic mild stress on sexual behavior, locomotor activity and consumption of sucrose and saccharine solutions. Physiol Behav 2005, 84:571-577.
34. Gutierrez-Rojas C., Pascual R., Bustamante C. Prenatal stress alters the behavior and dendritic morphology of the medial orbitofrontal cortex in mouse offspring during lactation. Int J Dev Neurosci 2013, 31:505-511.
35. Handley S.L., Mithani S. Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of 'fear'-motivated behaviour. Naunyn Schmiedebergs Arch Pharmacol 1984, 327:1-5.
36. Hill M.N., Hellemans K.G.C., Verma P., Gorzalka B.B., Weinberg J. Neurobiology of chronic mild stress: parallels to major depression. Neurosci Biobehav Rev 2012, 36:2085-2117.
37. Hill M.N., Kumar S.A., Filipski S.B., Iverson M., Stuhr K.L., Keith J.M., Cravatt B.F., Hillard C.J., Chattarji S., McEwen B.S. Disruption of fatty acid amide hydrolase activity prevents the effects of chronic stress on anxiety and amygdalar microstructure. Mol Psychiatry 2013, 18:1125-1135.
38. Hobfoll S.E., Ritter C., Lavin J., Hulsizer M.R., Cameron R.P. Depression prevalence and incidence among inner-city pregnant and postpartum women. J Consult Clin Psychol 1995, 63:445-453.
39. Holloway T., Moreno J.L., Umali A., Rayannavar V., Hodes G.E., Russo S.J., Gonzalez-Maeso J. Prenatal Stress induces schizophrenia-like alterations of serotonin 2A and metabotropic glutamate 2 receptors in the adult offspring: role of maternal immune system. J Neurosci 2013, 33:1088-1098.
40. Holmes A. Targeted gene mutation approaches to the study of anxiety-like behavior in mice. Neurosci Biobehav Rev 2001, 25:261-273.
41. Ishiwata H., Shiga T., Okado N. Selective serotonin reuptake inhibitor treatment of early postnatal mice reverses their prenatal stress-induced brain dysfunction. Neuroscience 2005, 133:893-901.
42. Johns J.M., Joyner P.W., McMurray M.S., Elliott D.L., Hofler V.E., Middleton C.L., Knupp K., Greenhill K.W., Lomas L.M., Walker C.H. The effects of dopaminergic/serotonergic reuptake inhibition on maternal behavior, maternal aggression, and oxytocin in the rat. Pharmacol Biochem Behav 2005, 81:769-785.
43. Karpova N.N., Lindholm J., Pruunsild P., Timmusk T., Castrén E. Long-lasting behavioural and molecular alterations induced by early postnatal fluoxetine exposure are restored by chronic fluoxetine treatment in adult mice. Eur Neuropsychopharmacol 2009, 19:97-108.
44. Katz R.J., Roth K.A., Carroll B.J. Acute and chronic stress effects on open field activity in the rat: implications for a model of depression. Neurosci Biobehav Rev 1981, 5:247-251.
45. Kessler R.C. The effects of stressful life events on depression. Annu Rev Psychol 1997, 48:191-214.
46. Kim J., Riggs K.W., Misri S., Kent N., Oberlander T., Grunau R., Fitzgerald C., Rurak D. Stereoselective disposition of fluoxetine and norfluoxetine during pregnancy and breast-feeding. Br J Clin Pharmacol 2006, 61:155-163.
47. Kinney D.K., Munir K.M., Crowley D.J., Miller A.M. Prenatal stress and risk for autism. Neurosci Biobehav Rev 2008, 32:1519-1532.
48. Kinsley C., Svare B. Prenatal stress reduces intermale aggression in mice. Physiol Behav 1986, 36:783-786.
49. Kinsley C., Svare B. Genotype modulates prenatal stress effects on aggression in male and female mice. Behav Neural Biol 1987, 47:138-150.
50. Kiryanova V., Dyck R.H. Increased aggression, improved spatial memory, and reduced anxiety-like behaviour in adult male mice exposed to fluoxetine early in life. Dev Neurosci 2014, 36:396-408.
51. Kiryanova V., McAllister B.B., Dyck R.H. Long-term outcomes of developmental exposure to fluoxetine: a review of the animal literature. Dev Neurosci 2013, 35:437-439.
52. Kiryanova V., Smith V.M., Dyck R.H., Antle M.C. The effects of perinatal fluoxetine treatment on the circadian system of the adult mouse. Psychopharmacology (Berl) 2013, 225:743-751.
53. Kitamura T., Shima S., Sugawara M., Toda M.A. Psychological and social correlates of the onset of affective disorders among pregnant women. Psychol Med 1993, 23:967-975.
54. Knaepen L., Rayen I., Charlier T.D., Fillet M., Houbart V., van Kleef M., Steinbusch H.W., Patijn J., Tibboel D., Joosten E.A., Pawluski J.L. Developmental fluoxetine exposure normalizes the long-term effects of maternal stress on post-operative pain in sprague-dawley rat offspring. PLoS One 2013, 8.
55. Koenig J.I., Elmer G.I., Shepard P.D., Lee P.R., Mayo C., Joy B., Hercher E., Brady D.L. Prenatal exposure to a repeated variable stress paradigm elicits behavioral and neuroendocrinological changes in the adult offspring: potential relevance to schizophrenia. Behav Brain Res 2005, 156:251-261.
56. Krishnan V., Nestler E.J. The molecular neurobiology of depression. Nature 2008, 455:894-902.
57. Kristensen J.H., Ilett K.F., Hackett L.P., Yapp P., Paech M., Begg E.J. Distribution and excretion of fluoxetine and norfluoxetine in human milk. Br J Clin Pharmacol 1999, 48:521-527.
58. Kusserow H., Davies B., Hortnagl H., Voigt I., Stroh T., Bert B., Deng D.R., Fink H., Veh R.W., Theuring F. Reduced anxiety-related behaviour in transgenic mice overexpressing serotonin 1A receptors. Brain Res Mol Brain Res 2004, 129:104-116.
59. Lang U.E., Gunther L., Scheuch K., Klein J., Eckhart S., Hellweg R., Danker-Hopfe H., Oehler J. Higher BDNF concentrations in the hippocampus and cortex of an aggressive mouse strain. Behav Brain Res 2009, 197:246-249.
60. Lehmann J., Stohr T., Feldon J. Long-term effects of prenatal stress experiences and postnatal maternal separation on emotionality and attentional processes. Behav Brain Res 2000, 107:133-144.
61. Lester B.M., Cucca J., Andreozzi L., Flanagan P., Oh W. Possible association between fluoxetine hydrochloride and colic in an infant. J Am Acad Child Adolesc Psychiatry 1993, 32:1253-1255.
62. Levinstein M.R., Samuels B.A. Mechanisms underlying the antidepressant response and treatment resistance. Front Behav Neurosci 2014, 8:208.
63. Lewis R.J., Johnson R.D., Angier M.K. The distribution of fluoxetine and norfluoxetine in postmortem fluids and tissues 2007, Federal Aviation Administration Civil Aerospace Medical Institute, Oklahoma City.
64. Lisboa S.F., Oliveira P.E., Costa L.C., Venancio E.J., Moreira E.G. Behavioral evaluation of male and female mice pups exposed to fluoxetine during pregnancy and lactation. Pharmacology 2007, 80:49-56.
65. Mandrioli R., Mercolini L., Saracino M.A., Raggi M.A. Selective serotonin reuptake inhibitors (SSRIs): therapeutic drug monitoring and pharmacological interactions. Curr Med Chem 2012, 19:1846-1863.
66. Marcus S.M., Flynn H.A., Blow F.C., Barry K.L. Depressive symptoms among pregnant women screened in obstetrics settings. J Women's Health 2003, 12:373-380.
67. Markham J.A., Mullins S.E., Koenig J.I. Periadolescent maturation of the prefrontal cortex is sex-specific and is disrupted by prenatal stress. J Comp Neurol 2013, 521:1828-1843.
68. Matrisciano F., Tueting P., Maccari S., Nicoletti F., Guidotti A. Pharmacological activation of group-II metabotropic glutamate receptors corrects a schizophrenia-like phenotype induced by prenatal stress in mice. Neuropsychopharmacology 2012, 37:929-938.
69. McAllister B.B., Kiryanova V., Dyck R.H. Behavioural outcomes of perinatal maternal fluoxetine treatment. Neuroscience 2012, 226:356-366.
70. McKee M.D., Cunningham M., Jankowski K.R., Zayas L. Health-related functional status in pregnancy: relationship to depression and social support in a multi-ethnic population. Obstet Gynecol 2001, 97:988-993.
71. Meek L.R., Dittel P.L., Sheehan M.C., Chan J.Y., Kjolhaug S.R. Effects of stress during pregnancy on maternal behavior in mice. Physiol Behav 2001, 72:473-479.
72. Mendes-da-Silva C., de Souza S.L., Barreto-Medeiros J.M., de Freitas-Silva S.R., Antunes D.E.C., Cunha A.D.U., Ribas V.R., de França M.F.S., Nogueira M.I., Manhães-de-Castro R. Neonatal treatment with fluoxetine reduces depressive behavior induced by forced swim in adult rats. Arq Neuropsiquiatr 2002, 60:928-931.
73. Mitchell A.A., Gilboa S.M., Werler M.M., Kelley K.E., Louik C., Hernandez-Diaz S., National Birth Defects Prevention Study Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008. Am J Obstet Gynecol 2011, 205. 51.e51-58.
74. Miyagawa K., Tsuji M., Fujimori K., Saito Y., Takeda H. Prenatal stress induces anxiety-like behavior together with the disruption of central serotonin neurons in mice. Neurosci Res 2011, 70:111-117.
75. Monroe S.M., Hadjiyannakis K. The social environment and depression: focusing on severe life stress. Handbook of depression 2002, 314-340. Guilford, New York. I.H. Gotlib, C.L. Hammen (Eds.).
76. Moore T.M., Scarpa A., Raine A. A meta-analysis of serotonin metabolite 5-HIAA and antisocial behavior. Aggressive Behav 2002, 28:299-316.
77. Morley-Fletcher S., Mairesse J., Soumier A., Banasr M., Fagioli F., Gabriel C., Mocaer E., Daszuta A., McEwen B., Nicoletti F., Maccari S. Chronic agomelatine treatment corrects behavioral, cellular, and biochemical abnormalities induced by prenatal stress in rats. Psychopharmacology (Berl) 2011, 217:301-313.
78. Morrison J.L., Riggs K.W., Rurak D.W. Fluoxetine during pregnancy: impact on fetal development. Reprod Fertil Dev 2005, 17:641-650.
79. Murmu M.S., Salomon S., Biala Y., Weinstock M., Braun K., Bock J. Changes of spine density and dendritic complexity in the prefrontal cortex in offspring of mothers exposed to stress during pregnancy. Eur J Neurosci 2006, 24:1477-1487.
80. Mychasiuk R., Gibb R., Kolb B. Prenatal stress alters dendritic morphology and synaptic connectivity in the prefrontal cortex and hippocampus of developing offspring. Synapse (New York, NY) 2012, 66:308-314.
81. Nagano M., Liu M., Inagaki H., Kawada T., Suzuki H. Early intervention with fluoxetine reverses abnormalities in the serotonergic system and behavior of rats exposed prenatally to dexamethasone. Neuropharmacology 2012, 63:292-300.
82. Nautiyal K.M., Tanaka K.F., Barr M.M., Tritschler L., Le Dantec Y., David D.J., Gardier A.M., Blanco C., Hen R., Ahmari S.E. Distinct circuits underlie the effects of 5-HT1B receptors on aggression and impulsivity. Neuron 2015, 86:813-826.
83. Nishio H., Kasuga S., Ushijima M., Harada Y. Prenatal stress and postnatal development of neonatal rats-sex-dependent effects on emotional behavior and learning ability of neonatal rats. Int J Dev Neurosci 2001, 19:37-45.
84. Noorlander C.W., Ververs F.F.T., Nikkels P.G.J., van Echteld C.J.A., Visser G.H.A., Smidt M.P. Modulation of serotonin transporter function during fetal development causes dilated heart cardiomyopathy and lifelong behavioral abnormalities. PLoS One 2008, 3.
85. Nordquist N., Oreland L. Serotonin, genetic variability, behaviour, and psychiatric disorders-a review. Ups J Med Sci 2010, 115:2-10.
86. Olivier J.D.A., Valles A., van Heesch F., Afrasiab-Middelman A., Roelofs J.J.P.M., Jonkers M., Peeters E.J., Korte-Bouws G.A.H., Dederen J.P., Kiliaan A.J., Martens G., Schubert D., Homberg J. Fluoxetine administration to pregnant rats increases anxiety-related behavior in the offspring. Psychopharmacology (Berl) 2011, 217:419-432.
87. Palanza P.L., Howdeshell K.L., Parmigiani S., vom Saal F.S. Exposure to a low dose of bisphenol A during fetal life or in adulthood alters maternal behavior in mice. Environ Health Perspect 2002, 110(Suppl. 3):415-422.
88. Patin V., Lordi B., Vincent A., Caston J. Effects of prenatal stress on anxiety and social interactions in adult rats. Brain Res Dev Brain Res 2005, 160:265-274.
89. Pawluski J.L., Charlier T.D., Fillet M., Houbart V., Crispin H.T., Steinbusch H.W., van den Hove D.L. Chronic fluoxetine treatment and maternal adversity differentially alter neurobehavioral outcomes in the rat dam. Behav Brain Res 2012, 228:159-168.
90. Pawluski J.L., Rayen I., Niessen N.A., Kristensen S., van Donkelaar E.L., Balthazart J., Steinbusch H.W., Charlier T.D. Developmental fluoxetine exposure differentially alters central and peripheral measures of the HPA system in adolescent male and female offspring. Neuroscience 2012, 220:131-141.
91. Pedersen C.A., Vadlamudi S.V., Boccia M.L., Amico J.A. Maternal behavior deficits in nulliparous oxytocin knockout mice. Genes Brain Behav 2006, 5:274-281.
92. Peters D.A. Prenatal stress: effects on brain biogenic amine and plasma corticosterone levels. Pharmacol Biochem Behav 1982, 17:721-725.
93. Peters D.A. Maternal stress increases fetal brain and neonatal cerebral cortex 5-hydroxytryptamine synthesis in rats: a possible mechanism by which stress influences brain development. Pharmacol Biochem Behav 1990, 35:943-947.
94. Raap D.K., Garcia F., Muma N.A., Wolf W.A., Battaglia G., van de Kar L.D. Sustained desensitization of hypothalamic 5-Hydroxytryptamine1A receptors after discontinuation of fluoxetine: inhibited neuroendocrine responses to 8-hydroxy-2-(Dipropylamino)Tetralin in the absence of changes in Gi/o/z proteins. J Pharmacol Exp Ther 1999, 288:561-567.
95. Rayen I., Gemmel M., Pauley G., Steinbusch H.W.M., Pawluski J.L. Developmental exposure to SSRIs, in addition to maternal stress, has long-term sex-dependent effects on hippocampal plasticity. Psychopharmacology (Berl) 2015, 232:1231-1244.
96. Rayen I., Steinbusch H.W.M., Charlier T.D., Pawluski J.L. Developmental fluoxetine exposure and prenatal stress alter sexual differentiation of the brain and reproductive behavior in male rat offspring. Psychoneuroendocrinology 2013, 38:1618-1629.
97. Rayen I., van den Hove D.L., Prickaerts J., Steinbusch H.W., Pawluski J.L. Fluoxetine during development reverses the effects of prenatal stress on depressive-like behavior and hippocampal neurogenesis in adolescence. PLoS One 2011, 6.
98. Rebello T.J., Yu Q., Goodfellow N.M., Caffrey Cagliostro M.K., Teissier A., Morelli E., Demireva E.Y., Chemiakine A., Rosoklija G.B., Dwork A.J., Lambe E.K., Gingrich J.A., Ansorge M.S. Postnatal day 2 to 11 constitutes a 5-HT-sensitive period impacting adult mPFC function. J Neurosci 2014, 34:12379-12393.
99. Rodgers R.J., Johnson N.J. Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety. Pharmacol Biochem Behav 1995, 52:297-303.
100. Rodriguez A., Bohlin G. Are maternal smoking and stress during pregnancy related to ADHD symptoms in children?. J Child Psychol Psychiatry Allied Disciplines 2005, 46:246-254.
101. Romijn H.J., Hofman M.A., Gramsbergen A. At what age is the developing cerebral cortex of the rat comparable to that of the full-term newborn human baby?. Early Hum Dev 1991, 26:61-67.
102. Ronald A., Pennell C.E., Whitehouse A.J.O. Prenatal maternal stress associated with ADHD and autistic traits in early childhood. Front Psychol 2010, 1:223.
103. Schraut K.G., Jakob S.B., Weidner M.T., Schmitt A.G., Scholz C.J., Strekalova T., El Hajj N., Eijssen L.M.T., Domschke K., Reif A., Haaf T., Ortega G., Steinbusch H.W.M., Lesch K.P., Van den Hove D.L. Prenatal stress-induced programming of genome-wide promoter DNA methylation in 5-HTT-deficient mice. Transl Psychiatry 2014, 4:e473.
104. Singh Y., Jaiswal A.K., Singh M., Bhattacharya S.K. Effect of prenatal diazepam, phenobarbital, haloperidol and fluoxetine exposure on foot shock induced aggression in rats. Indian J Exp Biol 1998, 36:1023-1024.
105. Smith J.W., Seckl J.R., Evans A.T., Costall B., Smythe J.W. Gestational stress induces post-partum depression-like behaviour and alters maternal care in rats. Psychoneuroendocrinology 2004, 29:227-244.
106. Stohr T., Schulte Wermeling D., Szuran T., Pliska V., Domeney A., Welzl H., Weiner I., Feldon J. Differential effects of prenatal stress in two inbred strains of rats. Pharmacol Biochem Behav 1998, 59:799-805.
107. Strekalova T., Spanagel R., Dolgov O., Bartsch D. Stress-induced hyperlocomotion as a confounding factor in anxiety and depression models in mice. Behav Pharmacol 2005, 16:171-180.
108. Talge N.M., Neal C., Glover V., Early Stress, Translational Research and Prevention Science Network: Fetal and Neonatal Experience on Child and Adolescent Mental Health Antenatal maternal stress and long-term effects on child neurodevelopment: how and why?. J Child Psychol Psychiatry Allied Disciplines 2007, 48:245-261.
109. Tennant C. Life events, stress and depression: a review of recent findings. Aust N Z J Psychiatry 2002, 36:173-182.
110. Tsuda M.C., Yamaguchi N., Ogawa S. Early life stress disrupts peripubertal development of aggression in male mice. Neuroreport 2011, 22:259-263.
111. Vallee M., MacCari S., Dellu F., Simon H., Le Moal M., Mayo W. Long-term effects of prenatal stress and postnatal handling on age-related glucocorticoid secretion and cognitive performance: a longitudinal study in the rat. Eur J Neurosci 1999, 11:2906-2916.
112. Vallee M., Mayo W., Dellu F., Le Moal M., Simon H., Maccari S. Prenatal stress induces high anxiety and postnatal handling induces low anxiety in adult offspring: correlation with stress-induced corticosterone secretion. J Neurosci 1997, 17:2626-2636.
113. van den Hove D.L.A., Van den Hove D., Jakob S.B., Schraut K.-G., Kenis G., Schmitt A.G., Kneitz S., Scholz C.-J., Wiescholleck V., Ortega G., Prickaerts J., Steinbusch H., Lesch K.-P. Differential effects of prenatal stress in 5-Htt deficient mice: towards molecular mechanisms of gene * environment interactions. PLoS One 2011, 6.
114. Vinkers C.H., Oosting R.S., van Bogaert M.J.V., Olivier B., Groenink L. Early-life blockade of 5-HT(1A) receptors alters adult anxiety behavior and benzodiazepine sensitivity. Biol Psychiatry 2010, 67:309-316.
115. Vorhees C.V., Williams M.T. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc 2006, 1:848-858.
116. Ward I.L. Prenatal stress feminizes and demasculinizes the behavior of males. Science (New York, NY) 1972, 175:82-84.
117. Wood G.E., Young L.T., Reagan L.P., McEwen B.S. Acute and chronic restraint stress alter the incidence of social conflict in male rats. Horm Behav 2003, 43:205-213.
118. Yohe L.R., Suzuki H., Lucas L.R. Aggression is suppressed by acute stress but induced by chronic stress: immobilization effects on aggression, hormones, and cortical 5-HT(1B)/striatal dopamine D(2) receptor density. Cogn Affect Behav Neurosci 2012, 12:446-459.
119. Zimmerberg B., Blaskey L.G. Prenatal stress effects are partially ameliorated by prenatal administration of the neurosteroid allopregnanolone. Pharmacol Biochem Behav 1998, 59:819-827.